Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona
Se describen formas cristalinas del Compuesto (I). El Compuesto (I) es útil como agente anti-tromboembólico en el tratamiento de enfermedades cardiovasculares. Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular d...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SMITH, Daniel CLEEREN, Dirk Angelina J DILGER, Andrew K AHUJA, Dipali ZIEMBA, Theresa M XIOURAS, Christos LÜDEKER, David GALELLA, Michael A |
| description | Se describen formas cristalinas del Compuesto (I). El Compuesto (I) es útil como agente anti-tromboembólico en el tratamiento de enfermedades cardiovasculares.
Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CO2022016067A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CO2022016067A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CO2022016067A23</originalsourceid><addsrcrecordid>eNqNjUFqwzAQRbPporS9Q6AbGzTGIzlKsiyhobtuugshDPKYDMiSkVUoKb1rj1IRcoDCwH-L9__cL373MY00L12SOZOXULjnZbVNCs1cAxr47uCwAudjiqCh6m6IZ0CllYGchC7RA4L4euAg_ggW4ldRlIVeztKnOEmSUXoJV-0HDFS9DP6zLI2cSxG2cAUwqlNrhSvInBPRhcq-k_LzgLoxDTatVvYYXaaeHQFWuKmVrmxdeljOwsQhEwfYQAz0uLgbyM_8dMuHxfP-9WP3BjzFE88TOQ6cT7t33Wrdom3t-kWb_1l_iAVgxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona</title><source>esp@cenet</source><creator>SMITH, Daniel ; CLEEREN, Dirk Angelina J ; DILGER, Andrew K ; AHUJA, Dipali ; ZIEMBA, Theresa M ; XIOURAS, Christos ; LÜDEKER, David ; GALELLA, Michael A</creator><creatorcontrib>SMITH, Daniel ; CLEEREN, Dirk Angelina J ; DILGER, Andrew K ; AHUJA, Dipali ; ZIEMBA, Theresa M ; XIOURAS, Christos ; LÜDEKER, David ; GALELLA, Michael A</creatorcontrib><description>Se describen formas cristalinas del Compuesto (I). El Compuesto (I) es útil como agente anti-tromboembólico en el tratamiento de enfermedades cardiovasculares.
Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230126&DB=EPODOC&CC=CO&NR=2022016067A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230126&DB=EPODOC&CC=CO&NR=2022016067A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMITH, Daniel</creatorcontrib><creatorcontrib>CLEEREN, Dirk Angelina J</creatorcontrib><creatorcontrib>DILGER, Andrew K</creatorcontrib><creatorcontrib>AHUJA, Dipali</creatorcontrib><creatorcontrib>ZIEMBA, Theresa M</creatorcontrib><creatorcontrib>XIOURAS, Christos</creatorcontrib><creatorcontrib>LÜDEKER, David</creatorcontrib><creatorcontrib>GALELLA, Michael A</creatorcontrib><title>Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona</title><description>Se describen formas cristalinas del Compuesto (I). El Compuesto (I) es útil como agente anti-tromboembólico en el tratamiento de enfermedades cardiovasculares.
Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUFqwzAQRbPporS9Q6AbGzTGIzlKsiyhobtuugshDPKYDMiSkVUoKb1rj1IRcoDCwH-L9__cL373MY00L12SOZOXULjnZbVNCs1cAxr47uCwAudjiqCh6m6IZ0CllYGchC7RA4L4euAg_ggW4ldRlIVeztKnOEmSUXoJV-0HDFS9DP6zLI2cSxG2cAUwqlNrhSvInBPRhcq-k_LzgLoxDTatVvYYXaaeHQFWuKmVrmxdeljOwsQhEwfYQAz0uLgbyM_8dMuHxfP-9WP3BjzFE88TOQ6cT7t33Wrdom3t-kWb_1l_iAVgxw</recordid><startdate>20230126</startdate><enddate>20230126</enddate><creator>SMITH, Daniel</creator><creator>CLEEREN, Dirk Angelina J</creator><creator>DILGER, Andrew K</creator><creator>AHUJA, Dipali</creator><creator>ZIEMBA, Theresa M</creator><creator>XIOURAS, Christos</creator><creator>LÜDEKER, David</creator><creator>GALELLA, Michael A</creator><scope>EVB</scope></search><sort><creationdate>20230126</creationdate><title>Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona</title><author>SMITH, Daniel ; CLEEREN, Dirk Angelina J ; DILGER, Andrew K ; AHUJA, Dipali ; ZIEMBA, Theresa M ; XIOURAS, Christos ; LÜDEKER, David ; GALELLA, Michael A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CO2022016067A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SMITH, Daniel</creatorcontrib><creatorcontrib>CLEEREN, Dirk Angelina J</creatorcontrib><creatorcontrib>DILGER, Andrew K</creatorcontrib><creatorcontrib>AHUJA, Dipali</creatorcontrib><creatorcontrib>ZIEMBA, Theresa M</creatorcontrib><creatorcontrib>XIOURAS, Christos</creatorcontrib><creatorcontrib>LÜDEKER, David</creatorcontrib><creatorcontrib>GALELLA, Michael A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMITH, Daniel</au><au>CLEEREN, Dirk Angelina J</au><au>DILGER, Andrew K</au><au>AHUJA, Dipali</au><au>ZIEMBA, Theresa M</au><au>XIOURAS, Christos</au><au>LÜDEKER, David</au><au>GALELLA, Michael A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona</title><date>2023-01-26</date><risdate>2023</risdate><abstract>Se describen formas cristalinas del Compuesto (I). El Compuesto (I) es útil como agente anti-tromboembólico en el tratamiento de enfermedades cardiovasculares.
Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CO2022016067A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Formas cristalinas de (9r,13s)-13-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1,6-dihidropirimidin-1-il}-3-(difluorometil)-9-metil-3,4,7,15-tetraazatriciclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-ona |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A53%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMITH,%20Daniel&rft.date=2023-01-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECO2022016067A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |